quinupristin/dalfopristin will raise the degree or influence of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. CYP3A4 inhibitors may perhaps lessen avanafil clearance rising systemic exposure to avanafil; amplified concentrations might result in increased inv